Latest round: Post IPO debt. Anirvan Ghosh is the CEO of UNITY Biotechnology, a biotech company focused on senotherapeutics for age-related eye diseases.
Anirvan Ghosh is the CEO of UNITY Biotechnology, a biotech company focused on senotherapeutics for age-related eye diseases and neurological conditions. He has a background in neuroscience, ophthalmology, and oncology, having also held senior R&D roles at Biogen and Roche.
Full founder directory · Investor directory · Company funding database · Fundraising library